DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
M••••••
Healthcare & Pharmaceuticalsgroup grade Boff every schedule since Sep 30, 2025sponsor unattributed
Nothing material in the last 200 days. No dated change on record yet.
Mark path, consensus per quarter end
100¢ · 101¢ · 100¢ · 101¢ · 100¢Q3 2024 to Q3 2025
Principal held
at least $510,724
sum of BDC pieces, a lower bound
Fair value
$512,356
100c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Apr 15, 2031
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Sep 30, 2025
Events
3
dated, non-routine
Lender marks
each lender's own fair value over cost at Sep 30, 2025, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| A•••• C••••• B•• I••• | $511K | 100¢ | -1 pts |
Every BDC piece · 1 position across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A•••• C••••• B•• I••• | term loan first lien Investment T••• S••••• S•••••• T•••• A•••••••• R••••••••• T••• L••• (F•••• L•••) I•••• S+ | $510,724 | $512,356 100c | SOFR+325 bp |
Capital structure as the BDCs see it
latest quarter end Sep 30, 2025
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Sep 30, 2025 | at least $510,724 | 100c | SOFR+325 bp | Apr 15, 2031 | 1 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Sep 30, 2025 | 1 | $510,724 | $512,356 | 100c | 0 |
| Jun 30, 2025 | 1 | $512,004 | $514,656 | 101c | 0 |
| Mar 31, 2025 | 1 | $512,004 | $511,899 | 100c | 0 |
| Dec 31, 2024 | 1 | $1.0M | $1.0M | 101c | 0 |
All 11 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Sep 30, 2024 | 1 | $514,577 | $515,974 | 100c | 0 |
| Jun 30, 2024 | 1 | $514,577 | $515,014 | 100c | 0 |
| Mar 31, 2024 | 1 | $514,577 | $514,541 | 100c | 0 |
| Dec 31, 2023 | 1 | $1.0M | $1.0M | 100c | 0 |
| Sep 30, 2023 | 1 | $517,271 | $495,088 | 96c | 0 |
| Jun 30, 2023 | 1 | $518,618 | $482,872 | 93c | 0 |
| Dec 31, 2022 | 1 | $521,312 | $515,447 | 99c | 0 |
What changed
- Facility left every BDC scheduleSep 30, 2025
- Maturity extended (observed)Jun 30, 2024
- Maturity extended (observed)Jun 30, 2024
- Marked down across lendersJun 30, 2023
- Marked down (one lender)Jun 30, 2023
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- MYEYEDRderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it